194 related articles for article (PubMed ID: 22354369)
21. Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases.
Shields CL; Shields JA; Cater J; Lois N; Edelstein C; Gündüz K; Mercado G
Ophthalmology; 1998 Apr; 105(4):581-90. PubMed ID: 9544628
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy].
Bogdali A; Romanowska-Dixon B
Klin Oczna; 2015; 117(3):169-72. PubMed ID: 26999940
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal aflibercept for the treatment of radiation-induced macular edema after ruthenium 106 plaque radiotherapy for choroidal melanoma.
Fallico M; Reibaldi M; Avitabile T; Longo A; Bonfiglio V; Chronopoulos A; Caltabiano R; Spatola C; Russo A
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1547-1554. PubMed ID: 31081526
[TBL] [Abstract][Full Text] [Related]
24. AVATAR: Analysis for Visual Acuity Prediction After Eye Interventional Radiotherapy.
Pagliara MM; Tagliaferri L; Lenkowicz J; Azario L; Giattini D; Fionda B; Sammarco MG; Lancellotta V; Gambacorta MA; Blasi MA
In Vivo; 2020; 34(1):381-387. PubMed ID: 31882502
[TBL] [Abstract][Full Text] [Related]
25. Combined brachytherapy and transpupillary thermotherapy for large choroidal melanoma: tumor regression and early complications.
Kreusel KM; Bechrakis N; Riese J; Krause L; Wachtlin J; Foerster MH
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1575-80. PubMed ID: 16738857
[TBL] [Abstract][Full Text] [Related]
26. Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.
Hegde JV; McCannel TA; McCannel CA; Lamb J; Wang PC; Veruttipong D; Almanzor R; Demanes DJ; Kamrava M
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1843-1850. PubMed ID: 28597076
[TBL] [Abstract][Full Text] [Related]
27. Predictive factors of visual outcome after local resection of choroidal melanoma.
Damato BE; Paul J; Foulds WS
Br J Ophthalmol; 1993 Oct; 77(10):616-23. PubMed ID: 8218028
[TBL] [Abstract][Full Text] [Related]
28. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome.
De Potter P; Shields CL; Shields JA; Cater JR; Brady LW
Arch Ophthalmol; 1996 Nov; 114(11):1357-65. PubMed ID: 8906026
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma.
Lommatzsch PK; Werschnik C; Schuster E
Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):129-37. PubMed ID: 10766281
[TBL] [Abstract][Full Text] [Related]
30. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
31. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
32. Optical coherence tomography angiography-based analysis of intrinsic vasculature in juxtapapillary melanoma after ruthenium-106 plaque brachytherapy.
Shanmugam PM; Konana VK; Ramanjulu R; Mishra KCD; Sagar P; Kumar D
Indian J Ophthalmol; 2019 Dec; 67(12):2086-2088. PubMed ID: 31755470
[TBL] [Abstract][Full Text] [Related]
33. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
34. OCT changes in peri-tumour normal retina following ruthenium-106 and proton beam radiotherapy for uveal melanoma.
Hussain R; Heussen FM; Heimann H
Br J Ophthalmol; 2021 May; 105(5):648-652. PubMed ID: 32586936
[TBL] [Abstract][Full Text] [Related]
35. Plaque brachytherapy for uveal melanoma: a vision prognostication model.
Khan N; Khan MK; Bena J; Macklis R; Singh AD
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e285-90. PubMed ID: 22658514
[TBL] [Abstract][Full Text] [Related]
36. Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?
Chiam PJ; Coupland SE; Kalirai H; Groenewald C; Heimann H; Damato BE
Br J Ophthalmol; 2014 Jul; 98(7):967-71. PubMed ID: 24518077
[TBL] [Abstract][Full Text] [Related]
37. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
[TBL] [Abstract][Full Text] [Related]
38. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
[TBL] [Abstract][Full Text] [Related]
39. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
[TBL] [Abstract][Full Text] [Related]
40. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
Finger PT; Chin KJ; Tena LB
Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]